Literature DB >> 10965921

Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.

N Udagawa1, N Takahashi, H Yasuda, A Mizuno, K Itoh, Y Ueno, T Shinki, M T Gillespie, T J Martin, K Higashio, T Suda.   

Abstract

Osteoprotegerin (OPG), a soluble decoy receptor for receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoclast differentiation factor, inhibits both differentiation and function of osteoclasts. We previously reported that OPG-deficient mice exhibited severe osteoporosis caused by enhanced osteoclastic bone resorption. In the present study, potential roles of OPG in osteoclast differentiation were examined using a mouse coculture system of calvarial osteoblasts and bone marrow cells prepared from OPG-deficient mice. In the absence of bone-resorbing factors, no osteoclasts were formed in cocultures of wild-type (+/+) or heterozygous (+/-) mouse-derived osteoblasts with bone marrow cells prepared from homozygous (-/-) mice. In contrast, homozygous (-/-) mouse-derived osteoblasts strongly supported osteoclast formation in the cocultures with homozygous (-/-) bone marrow cells, even in the absence of bone-resorbing factors. Addition of OPG to the cocultures with osteoblasts and bone marrow cells derived from homozygous (-/-) mice completely inhibited spontaneously occurring osteoclast formation. Adding 1alpha,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3] to these cocultures significantly enhanced osteoclast differentiation. In addition, bone-resorbing activity in organ cultures of fetal long bones derived from homozygous (-/-) mice was markedly increased, irrespective of the presence and absence of bone-resorbing factors, in comparison with that from wild-type (+/+) mice. Osteoblasts prepared from homozygous (-/-), heterozygous (+/-), and wild-type (+/+) mice constitutively expressed similar levels of RANKL messenger RNA, which were equally increased by the treatment with 1alpha,25(OH)2D3. When homozygous (-/-) mouse-derived osteoblasts and hemopoietic cells were cocultured, but direct contact between them was prevented, no osteoclasts were formed, even in the presence of 1alpha,25(OH)2D3 and macrophage colony-stimulating factor. These findings suggest that OPG produced by osteoblasts/stromal cells is a physiologically important regulator in osteoclast differentiation and function and that RANKL expressed by osteoblasts functions as a membrane-associated form.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965921     DOI: 10.1210/endo.141.9.7634

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  100 in total

1.  Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-κB and NF-κB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis.

Authors:  Ji H Kim; Subash C Gupta; Byoungduck Park; Vivek R Yadav; Bharat B Aggarwal
Journal:  Mol Nutr Food Res       Date:  2011-12-07       Impact factor: 5.914

2.  Effect of low-level laser therapy irradiation and Bio-Oss graft material on the osteogenesis process in rabbit calvarium defects: a double blind experimental study.

Authors:  Amir Alireza Rasouli Ghahroudi; Amir Reza Rokn; Katayoun A M Kalhori; Afshin Khorsand; Alireza Pournabi; A L B Pinheiro; Reza Fekrazad
Journal:  Lasers Med Sci       Date:  2013-08-31       Impact factor: 3.161

Review 3.  Novel host response therapeutic approaches to treat periodontal diseases.

Authors:  Keith L Kirkwood; Joni A Cirelli; Jill E Rogers; William V Giannobile
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

Review 4.  Circulating monocytes: an appropriate model for bone-related study.

Authors:  Y Zhou; H-W Deng; H Shen
Journal:  Osteoporos Int       Date:  2015-07-21       Impact factor: 4.507

5.  Cardiotrophin-like cytokine (CLCF1) modulates mesenchymal stem cell osteoblastic differentiation.

Authors:  Sarah Nahlé; Sarah Pasquin; Véronique Laplante; François Rousseau; Mukut Sharma; Jean-François Gauchat
Journal:  J Biol Chem       Date:  2019-06-27       Impact factor: 5.157

6.  Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis.

Authors:  Miaomiao Li; Shuying Yang; Ding Xu
Journal:  J Biol Chem       Date:  2016-10-03       Impact factor: 5.157

7.  Methionine-Restricted Diet Increases miRNAs That Can Target RUNX2 Expression and Alters Bone Structure in Young Mice.

Authors:  Jason Plummer; Miri Park; Frantz Perodin; Mark C Horowitz; Julie R Hens
Journal:  J Cell Biochem       Date:  2016-06-22       Impact factor: 4.429

8.  Immobilized-OPG-Fc on a titanium surface inhibits RANKL-dependent osteoclast differentiation in vitro.

Authors:  Seicho Makihira; Yuichi Mine; Hiroki Nikawa; Takahiro Shuto; Eduardo Kosaka; Masaru Sugiyama; Ryuji Hosokawa
Journal:  J Mater Sci Mater Med       Date:  2009-10-16       Impact factor: 3.896

Review 9.  Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases.

Authors:  A Sabokbar; D J Mahoney; F Hemingway; N A Athanasou
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

10.  Expression of receptor activator of nuclear factor -kappaB ligand, receptor activator of nuclear factor -kappaB, and osteoprotegerin, following low-level laser treatment on deproteinized bovine bone graft in rats.

Authors:  Yong-Deok Kim; Won-Wook Song; Seong-Sik Kim; Gyu-Cheon Kim; Dae-Seok Hwang; Sang-Hun Shin; Uk-Kyu Kim; Jong-Ryoul Kim; In-Kyo Chung
Journal:  Lasers Med Sci       Date:  2008-09-30       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.